Evidence map›Paper›PMID 39168183›Full record

ReviewThe Journal of biological chemistry2024

Recruitment, regulation, and release: Control of signaling enzyme localization and function by reversible S-acylation.

Xiaotian Zhang, Gareth M Thomas

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaotian ZhangDepartment of Neural Sciences, Center for Neural Development and Repair, Philadelphia, Pennsylvania, USA.
Gareth M ThomasDepartment of Neural Sciences, Center for Neural Development and Repair, Philadelphia, Pennsylvania, USA. Electronic address: gareth.thomas@temple.edu.

Funding

Regulation of Axonal Signaling by PalmitoylationR01NS094402 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI THOMAS, GARETH · 2015 to 2025
$3.7M
Palmitoylation-dependent Control of Glaucomatous NeurodegenerationR21EY029386 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI THOMAS, GARETH · 2019 to 2020
$454k
NEI NIH HHS R21 EY029386NINDS NIH HHS R01 NS094402
6 · The paper itself

Abstract

An ever-growing number of studies highlight the importance of S-acylation, a reversible protein-lipid modification, for diverse aspects of intracellular signaling. In this review, we summarize the current understanding of how S-acylation regulates perhaps the best-known class of signaling enzymes, protein kinases. We describe how S-acylation acts as a membrane targeting signal that localizes certain kinases to specific membranes, and how such membrane localization in turn facilitates the assembly of signaling hubs consisting of an S-acylated kinase's upstream activators and/or downstream targets. We further discuss recent findings that S-acylation can control additional aspects of the function of certain kinases, including their interactions and, surprisingly, their activity, and how such regulation might be exploited for potential therapeutic gain. We go on to describe the roles and regulation of de-S-acylases and how extracellular signals drive dynamic (de)S-acylation of certain kinases. We discuss how S-acylation has the potential to lead to "emergent properties" that alter the temporal profile and/or salience of intracellular signaling events. We close by giving examples of other S-acylation-dependent classes of signaling enzymes and by discussing how recent biological and technological advances should facilitate future studies into the functional roles of S-acylation-dependent signaling.

Indexed as

Signal TransductionAcylationAnimalsCell MembraneHumansProtein KinasesProtein Kinasesaxon degenerationaxon transportcancerDLKimmune signalingimmunityinflammationJNKneurodegenerationoncogenepalmitoylationprotein traffickingretrograde signalingsynapse

Identifiers

PMID39168183
PMCPMC11417247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.